跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,424 条关于
“complement C3”
全部
1,424
临床试验
361
药物
70
机构
2
资讯
991
上个月
Ancient Immune Protein C3 Boosts Cancer Immunotherapy When Produced Inside Tumors
9天前
FDA Clears IND for Alebund's First-in-Class IgA Protease AP308 in IgA Nephropathy
去年
Kriya Therapeutics Presents Promising Preclinical Data for KRIYA-825 Gene Therapy in Geographic Atrophy
去年
FDA Initiates Review of Roche's Monthly Injectable Crovalimab for Rare Blood Disorder PNH
去年
FDA Rejects Astellas' Label Update for Geographic Atrophy Drug Izervay
去年
Pegcetacoplan Shows Promise in C3G and IC-MPGN Treatment: VALIANT Trial
去年
Aviceda Therapeutics Secures $207.5 Million to Advance Geographic Atrophy Treatment
7个月前
Novartis Reports Positive Phase III Results for Fabhalta in Rare Kidney Disease C3 Glomerulopathy
去年
Ruxoprubart Receives FDA IND Clearance for Phase II Trials in IgAN and Dermatomyositis
去年
CDSCO Approves Novartis' Protocol Amendment for Iptacopan Study in Rare Kidney Disorders
第 1 页,共 100 页
上一页
下一页